Table 2.
Variable | Age, years | P value | |||
---|---|---|---|---|---|
0—4 | 5—9 | 10—14 | 15—19 | ||
Gender | 0.46 | ||||
Male | 40 | 10 | 31 | 62 | |
Female | 35 | 16 | 30 | 77 | |
Race | 0.6 | ||||
White | 62 | 17 | 46 | 115 | |
Black | 7 | 7 | 9 | 18 | |
AI | 0 | 0 | 1 | 1 | |
API | 5 | 2 | 4 | 4 | |
Primary site | 0.65 | ||||
Upper lobe | 25 | 6 | 16 | 34 | |
Middle lobe | 5 | 3 | 4 | 15 | |
Lower lobe | 24 | 6 | 18 | 52 | |
Overlapping | 4 | 2 | 3 | 7 | |
T and B | 6 | 6 | 9 | 19 | |
NOS | 11 | 3 | 11 | 12 | |
Laterality | 0.37 | ||||
Right | 36 | 12 | 30 | 77 | |
Left | 37 | 11 | 27 | 53 | |
Bilaterality | 1 | 3 | 2 | 8 | |
NOS | 1 | 0 | 2 | 1 | |
Histology | <0.01 | ||||
Carcinoid tumor | 1 | 1 | 23 | 64 | |
MEC | 3 | 11 | 9 | 14 | |
Adenocarcinoma | 2 | 5 | 12 | 12 | |
SCC | 0 | 1 | 1 | 10 | |
NET | 0 | 0 | 2 | 14 | |
Pulmonary blastoma | 59 | 3 | 3 | 2 | |
Atypical carcinoma | 0 | 0 | 1 | 6 | |
other | 10 | 5 | 10 | 17 | |
Grade | 0.02 | ||||
I | 4 | 7 | 11 | 31 | |
II | 2 | 3 | 10 | 15 | |
III | 3 | 2 | 4 | 9 | |
IV | 4 | 0 | 2 | 4 | |
Unknown | 62 | 14 | 34 | 80 | |
Surgery | 0.03 | ||||
Yes | 69 | 21 | 48 | 104 | |
No | 6 | 5 | 13 | 35 | |
TNM stage | <0.01 | ||||
I | 4 | 10 | 21 | 30 | |
II | 1 | 1 | 5 | 13 | |
III | 1 | 3 | 3 | 17 | |
IV | 1 | 2 | 7 | 23 | |
Unknown | 68 | 10 | 25 | 56 | |
Radiotherapy | 0.12 | ||||
yes | 6 | 0 | 4 | 18 | |
no | 69 | 26 | 57 | 121 | |
Chemotherapy | <0.01 | ||||
yes | 50 | 5 | 13 | 44 | |
no/unknown | 25 | 21 | 48 | 95 |
AI, American Indian/Alaska Native; API, Asian or Pacific Islander; T and B, Trachea and Main bronchus; Overlapping, Overlapping lesion of lung; MEC, mucoepidermoid carcinoma; SCC, squamous cell carcinoma; NET, neuroendocrine tumor.